CEO Skips Senate Hearing
This is a news story, published by Ars Technica, that relates primarily to Ralph de la Torre news.
Ralph de la Torre news
For more Ralph de la Torre news, you can click here:
more Ralph de la Torre newsNews about health policy
For more health policy news, you can click here:
more health policy newsArs Technica news
For more news from Ars Technica, you can click here:
more news from Ars TechnicaAbout the Otherweb
Otherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like this article about health policy, you might also like this article about
bipartisan subpoena. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest Senate hearing news, CEO news, news about health policy, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
SandersArs Technica
•CEO of “health care terrorists” faces contempt charges after Senate no-show
75% Informative
Ralph de la Torre , CEO of Steward Health Care System , was a no-show at a Senate hearing on Thursday .
Lawmakers subpoenaed him after a federal court order forced him to appear.
The Senate committee found him to be in contempt of Congress and will pursue criminal contempt charges.
VR Score
76
Informative language
75
Neutral language
34
Article tone
formal
Language
English
Language complexity
53
Offensive language
possibly offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
short-lived
External references
3
Source diversity
3
Affiliate links
no affiliate links